Archives202520242023202220212020201920182017201620152014201320122011 March 10, 2017Successful £4.1 Million Fund Raise Following the Close of the Accelerated Bookbuild Read More March 10, 2017Accelerated Bookbuild for the Issue of Equity Read More January 25, 2017Update on Lupuzor™ Pivotal Phase III Study – Full Analysis of Patient Recruitment Read More January 24, 2017Change of Adviser Read More December 22, 2016Update on Lupuzor™ Pivotal Phase III Study – Patient Recruitment Completed Read More November 16, 2016Update on Cancer Compound IPP-204106 ‘Nucant’ Read More November 09, 2016Notification of Major Interest by Legal & General Read More October 26, 2016TR1 Notification of Major Interest Read More October 21, 2016Proposed Accelerated Bookbuild for Vendor Placing and Issue of Equity Read More October 21, 2016Close of Accelerated Bookbuild Read More September 30, 2016INTERIM RESULTS ANNOUNCEMENT for the six months ended 30 June 2016 Read More September 14, 2016Update on Lupuzor’s Pivotal Phase III Study – 11 US Sites Now Open, 5 European Countries Now Recruiting Read More 1…1617181920…24
March 10, 2017Successful £4.1 Million Fund Raise Following the Close of the Accelerated Bookbuild Read More
January 25, 2017Update on Lupuzor™ Pivotal Phase III Study – Full Analysis of Patient Recruitment Read More
December 22, 2016Update on Lupuzor™ Pivotal Phase III Study – Patient Recruitment Completed Read More
September 14, 2016Update on Lupuzor’s Pivotal Phase III Study – 11 US Sites Now Open, 5 European Countries Now Recruiting Read More
